Report #2825569

Received Feb 10, 2025

Office visit

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 37 yrs
State: NC
Recovered: Unknown
Vaccinated: Jan 28, 2025
Onset: Jan 28, 2025
Days to onset: 0
Hospital days: —

Vaccines (3)

Type	Name	Manufacturer	Dose	Lot	Route / Site
ANTH	ANTHRAX (BIOTHRAX)	EMERGENT BIOSOLUTIONS	1	300214A	IM / LA
JEV1	JAPANESE ENCEPHALITIS (IXIARO)	INTERCELL AG	UNK	JEV23JO1E	—
TYP	TYPHOID VI POLYSACCHARIDE (TYPHIM VI)	SANOFI PASTEUR	1	W1A991M	IM / LA

Symptoms (4)

Injected limb mobility decreasedInjection site painInjection site swellingSleep disorder

Symptom narrative

Patient received 3 vaccines 28 Jan 2025 (typhoid #1, sanofi lot #W1A991M; anthrax #1 Emergent Biosolutions lot #30021A; JE-VC #1 Valneva lot #23J01E), all to her left deltoid. She reports onset of pain, tenderness, swelling to the injection site starting that night. She states it has improved but continues to be uncomfortable. She has difficulty with ROM due to pain, and disrupts sleep if lying on that side. She denies paresis or paralysis. She denies any prior AE after vaccine. She denies fever, chills, malaise, arthralgias, myalgias, CP, SOG or dermatitis. She had no immediate symptoms after receipt to suggest IgE mediated event